MedPath

河南科伦药业有限公司

Ownership
-
Established
2009-05-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

157

NMPA:157

Drug Approvals

Lidocaine and Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20253151
Approval Date
Jan 14, 2025
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247116
Approval Date
May 30, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247100
Approval Date
May 13, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247052
Approval Date
Mar 21, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247049
Approval Date
Mar 21, 2024
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20243105
Approval Date
Jan 30, 2024
NMPA

Cefmetazole Sodium for Injection and Sodium Chloride Injection

Product Name
注射用头孢美唑钠/氯化钠注射液
Approval Number
国药准字H20233838
Approval Date
Jun 30, 2023
NMPA

Multiple Electrolytes Injection(II)

Product Name
复方电解质注射液(Ⅱ)
Approval Number
国药准字H20233430
Approval Date
Apr 28, 2023
NMPA

Multiple Electrolytes Injection(II)

Product Name
复方电解质注射液(Ⅱ)
Approval Number
国药准字H20233452
Approval Date
Apr 11, 2023
NMPA

Cimetidine Injection

Product Name
西咪替丁注射液
Approval Number
国药准字H20065966
Approval Date
Nov 17, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.